Phongsaran Kimawaha
Khon Kaen, 40002, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Prognostic Values of Ferroptosis-Related Proteins ACSL4, SLC7A11, and CHAC1 in Cholangiocarcinoma.
Journal: Biomedicines
Published: August 08, 2024
Evaluation of HMGB1 Expression as a Clinical Biomarker for Cholangiocarcinoma.
Journal: Cancer genomics & proteomics
Published: July 25, 2024
Alteration of STK11 Expression Associated With Cholangiocarcinoma Progression.
Journal: In vivo (Athens, Greece)
Published: March 29, 2023
The novel epithelial-mesenchymal transition-related proteins and their therapeutic targets in cholangiocarcinoma: a narrative review.
Journal: Journal of gastrointestinal oncology
Published: November 09, 2022
Serum α2,6-sialylated glycoform of serotransferrin as a glycobiomarker for diagnosis and prediction of clinical severity in cholangiocarcinoma.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: May 24, 2022
Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: May 11, 2021
Establishment of a Potential Serum Biomarker Panel for the Diagnosis and Prognosis of Cholangiocarcinoma Using Decision Tree Algorithms.
Journal: Diagnostics (Basel, Switzerland)
Published: March 01, 2021
Circulating TGF-β1 as the potential epithelial mesenchymal transition-biomarker for diagnosis of cholangiocarcinoma.
Journal: Journal of gastrointestinal oncology
Published: May 14, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026